Some TPP Countries Allowed Transition Periods for Biologics Exclusivity
This article was originally published in PharmAsia News
Malaysia, Mexico, Peru and Vietnam would be permitted to have transition periods of five to 10 years in implementing the biologic marketing exclusivity rules agreed to under the Trans-Pacific Partnership (TPP), according to a document posted online on Oct. 9 by the anti-secrecy group WikiLeaks.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.